For patients and clinicians alike, it has long been a mystery why symptoms of multiple sclerosis (MS) seem to get better in the winter and worse in the summer. A group of researchers, led by Francisco J. Quintana, PhD, at the Ann Romney Center for Neurologic Diseases at Brigham and Women’s Hospital, and collaborators at the Center for Research on Neuroimmunological Diseases (CIEN) at the Raul Carrea Institute for Neurological Research (FLENI) in Argentina, have found an explanation that could lead to a deeper understanding of the disease and more targeted multiple sclerosis treatment options for patients.
More than 800,000 people have died of COVID-19 in the United States. Many families are confronting the winter holidays, a time traditionally devoted to celebration, while bearing the recent loss of a loved one.
Getting the influenza (flu) vaccine is more important than ever during the COVID-19 pandemic as we face the risk of both the flu virus and the coronavirus spreading at the same time. Learn more about how to educate your patients on how to protect themselves and those around them most at risk.
Brigham and Women’s Hospital is set to begin a clinical trial that will test the safety and efficacy of a new vaccine delivered nasally intended to prevent and slow the progression of Alzheimer’s disease (AD). Continue reading to learn more about the intranasal vaccine for Alzheimer's disease.